Subscribe to The Insides™ Company Newsletter
Stay up-to date & receive our latest news
The Insides™ Company's flagship product, The Insides™ System, is a medical device that enables chyme to be reinfused into the intestine for enterostomy and enterocutaneous fistula patients.
The Insides™ System is commercially available in the United Kingdom, Europe, and New Zealand.
*The Insides™ System is not currently approved for sales in the United States. Caution - Investigational Device, Limited by Federal Law to Investigational Use
-min.png)
The Insides™ Company is founded by world-leading pioneers in gut nutrition, and commercialised by med-tech veterans. The Insides System is now being used in multiple key international intestinal failure sites.
Please contact us today to learn about how The Insides System can impact your patient's journey to recovery.
Professor Ian Bisset
Co-Founder & Chief Medical Officer
Professor
Greg O’Grady
Co-Founder & Chief Scientific Officer
“The Insides System is revolutionising recovery times & patient well-being.”
*The Insides™ System is not currently approved for sales in the United States.
Caution - Investigational Device, Limited by Federal Law to Investigational Use
Under the standard care pathway, patients recovering from colorectal surgery often have an enterostomy created to divert intestinal contents (chyme) away from the surgical site as it heals.
The enterostomy is typically left open for 6-12 months, and during this time, the chyme that is collected is disposed which can result in intestinal failure
The Insides System, is a chyme reinfusion solution, which enables diverting enterostomy, and enterocutaneous patients to reinfuse chyme back into their intestine, allowing them to recommence oral feeding and reduce length of stay in hospital.
Earlier return to oral feeding
Patients able to recommence oral feeding
Improved nutritional outcome
Increase in nutritional risk index by 10.9 (± 9.5) with a 85% reduction in intestinal losses
Improved restoration of gut function
Reverse gut atrophy and inflammation and improved gut microbiome
Improved renal function
Prevents dehydration and reduces the potential for chronic kidney disease
Improved liver function
53% reduction in plasma liver test abnormalities
Wean off Parenteral Nutrition
>91% of patients weaned off parenteral nutrition within a median of 2 days (± 9)
Emma Ludlow
Clinical Nurse Specialist Ostomy
"The Insides™ System allows me to support, and optimise my patient’s journey to recovery."
.png){kind=small}
.png){kind=small}
